If you've been diagnosed with obstructive sleep apnea (OSA), you know that a continuous positive airway pressure (CPAP) ...
I would log six to eight hours of sleep where I was unconscious, but I wasn't getting what is ‘actual’ sleep,” said Orsini, 48, of Seven Fields, Pennsylvania. Like an estimated 30 million Americans, ...
Southern California Pulmonary and Sleep Disorders Medical Center has announced expanded access to Inspire therapy, offering a ...
LivaNova has published 12-month data supporting its proximal hypoglossal nerve stimulation (pHGNS) system for sleep apnea.
Dr. Thomas Gotsis DDS, DABDSM the Owner and President of Midwest Dental Sleep Medicine Institute chats with Angela about an ...
A randomized controlled trial evaluating the safety and efficacy of proximal hypoglossal nerve stimulation, or pHGNS, (an ...
Explore the best Apple Watch Ultra 3 alternatives, including high-performance models from Samsung, Garmin, and Huawei ...
With appropriate introduction of oral appliance therapy, more patients are seeing success in navigating sleep disorders and other comorbidities.
The FDA approved the first-ever medication for obstructive sleep apnea in December 2024, expanding a treatment landscape that has long centered on continuous positive airway pressure machines.
A randomized controlled trial evaluating the safety and efficacy of proximal hypoglossal nerve stimulation, or pHGNS, (an implanted stimulation therapy targeting specific sectors of nerves in the ...
TheFly reported on April 15 that Truist Financial reduced its price target for INSP from $70 to $64 while maintaining a Hold ...